CA
NZ
UK
AU
IND
US
Emergent BioSolutions is a life-sciences company built around public-health preparedness. Its portfolio spans the CYFENDUS and BioThrax anthrax vaccines, the ACAM2000 smallpox and mpox vaccine, botulism antitoxin (BAT), and the over-the-counter NARCAN naloxone nasal spray used to reverse opioid overdoses. Much of its revenue …
Cardio Diagnostics is a precision-cardiovascular-medicine company that combines epigenetics, genetics and artificial intelligence, using DNA-methylation biomarkers andMachine Learningto assess and detect coronary heart disease. Its core products are the Epi+Gen CHD risk-assessment test and the PrecisionCHD detection test, alongside its HeartRisk and CardioInnovate360 offerings. …
Bolt Biotherapeutics develops cancer immunotherapies built on its Boltbody Immune-Stimulating Antibody Conjugate, or ISAC, platform, which pairs tumor-targeting antibodies with immune-activating payloads. Its lead candidate, BDC-4182, is a next-generation ISAC targeting claudin 18.2 for gastric and gastroesophageal junction cancers, and it is advancing through …
Decoy Therapeutics develops AI-designed peptide-conjugate therapeutics through its IMP3ACT platform, which it uses to create what it calls Designable Multi-Antivirals, or D-MAVs, single drugs engineered to work across multiple viruses rather than one at a time. The company says it targets more than 250 …
Scopus BioPharma (SEC CIK 1772028) built its identity around developing novel therapeutics, with early programs positioned in immuno-oncology and gene-based medicine. The company completed a Nasdaq listing in late 2020 and, over the following years, pursued corporate restructuring and transactions involving its subsidiary assets. …
TransMedics (SEC CIK 1756262) develops and commercializes the Organ Care System (OCS), a portable platform designed to keep donor hearts, lungs and livers in a functioning, near-physiologic state outside the body rather than on traditional cold storage. The company has paired that hardware with …
GARRISON FILM PRODUCTIONS INC presents itself, by name, as a film and entertainment company - a sector mismatch relative to the health and technology theme under which the ticker was flagged. A full-text search of the SEC's EDGAR system returns no filings under that …
Organogenesis is a regenerative-medicine company focused on advanced wound care and surgical and sports medicine, with a portfolio that has long included skin-substitute and tissue products such as Apligraf and Dermagraft. In the second quarter of 2026, the company reported revenue of $42.8 million, …
BeyondSpring is a clinical-stage biopharmaceutical company developing plinabulin, a selective immunomodulating microtubule-binding agent, for cancer treatment. In 2026 the company reported notable clinical signals: Phase 2 data presented at ASCO showed a 58% two-year overall survival rate in metastatic non-small cell lung cancer patients …
Anavex is a clinical-stage biotechnology company listed on theNasdaqunder AVXL, developing oral small-molecule therapies for central-nervous-system disorders. Its lead candidate, blarcamesine (ANAVEX2-73), a sigma-1 receptor agonist, is being advanced for early Alzheimer's disease, with additional programs in Rett syndrome and Fragile X syndrome.
Please wait processing your request...